PROSHARES ULTRA RUSSELL 1000 VALUE
UVG was delisted on the 8th of January, 2015.
4 hedge funds and large institutions have $1.1M invested in PROSHARES ULTRA RUSSELL 1000 VALUE in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
119% more capital invested
Capital invested by funds: $503K → $1.1M (+$597K)
100% more funds holding
Funds holding: 2 → 4 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$343K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$149K |
| 3 |
Parallax Volatility Advisers
San Francisco,
California
|
+$73 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |
UVG Hedge Fund Activity: Q4 2014 in Review
4 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in PROSHARES ULTRA RUSSELL 1000 VALUE (UVG) for Q4 2014, worth a combined $1.1M — up 119% from $503K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new UVG positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $343K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $5K sold.
- 4 institutional investors held PROSHARES ULTRA RUSSELL 1000 VALUE (UVG) as of Q4 2014, up from 2 in Q3 2014.
- Funds reported $1.1M of PROSHARES ULTRA RUSSELL 1000 VALUE stock for Q4 2014, up 119% quarter-over-quarter.
- 3 funds opened new PROSHARES ULTRA RUSSELL 1000 VALUE positions in Q4 2014 and 1 closed out, a net change of +2 holders.
- The largest PROSHARES ULTRA RUSSELL 1000 VALUE buyer in Q4 2014 was Jane Street, an estimated $343K added.
- The largest PROSHARES ULTRA RUSSELL 1000 VALUE seller in Q4 2014 was Tower Research Capital (TRC), an estimated $5K sold.
Based on aggregated 13F filings for Q4 2014.